PRAPA, MALVINA
 Distribuzione geografica
Continente #
NA - Nord America 2.133
AS - Asia 1.362
EU - Europa 1.345
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 71
AF - Africa 27
OC - Oceania 9
Totale 5.122
Nazione #
US - Stati Uniti d'America 2.071
IT - Italia 542
SG - Singapore 463
CN - Cina 331
GB - Regno Unito 211
VN - Vietnam 159
HK - Hong Kong 146
BR - Brasile 124
DE - Germania 107
SE - Svezia 89
RU - Federazione Russa 67
FR - Francia 64
FI - Finlandia 49
KR - Corea 43
BD - Bangladesh 39
IE - Irlanda 38
UA - Ucraina 35
TR - Turchia 33
AL - Albania 29
JP - Giappone 27
CA - Canada 26
ID - Indonesia 25
IN - India 23
MX - Messico 23
BE - Belgio 21
AR - Argentina 17
NL - Olanda 17
ES - Italia 13
BG - Bulgaria 12
EC - Ecuador 11
PK - Pakistan 11
PL - Polonia 10
AU - Australia 9
AT - Austria 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
PT - Portogallo 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
NP - Nepal 4
SI - Slovenia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BB - Barbados 3
CO - Colombia 3
IR - Iran 3
JM - Giamaica 3
LK - Sri Lanka 3
LT - Lituania 3
RO - Romania 3
UY - Uruguay 3
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EU - Europa 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 5.053
Città #
Singapore 321
Ashburn 249
Santa Clara 230
Fairfield 154
Hong Kong 140
San Jose 121
Hefei 115
Chandler 114
Southend 100
Woodbridge 82
Ann Arbor 81
Houston 76
Seattle 66
Ho Chi Minh City 58
Wilmington 57
Cambridge 53
Bologna 52
Beijing 49
Council Bluffs 49
Milan 49
Modena 48
London 47
Nyköping 47
Dearborn 43
Los Angeles 42
New York 42
Hanoi 41
Seoul 39
Helsinki 38
Dublin 37
Munich 35
The Dalles 32
Jacksonville 26
Tirana 22
Jakarta 20
Lauterbourg 20
Rome 20
San Diego 20
Brussels 19
Florence 18
Chicago 17
São Paulo 17
Dallas 16
Moscow 15
Parma 15
Buffalo 13
Frankfurt am Main 13
Boardman 12
Izmir 12
Orem 12
Reggio Emilia 12
Tokyo 12
Fremont 11
Phoenix 11
Falls Church 10
Mexico City 10
Nuremberg 10
Princeton 10
Sofia 10
Redondo Beach 9
San Giuliano Milanese 9
Warsaw 9
Adelaide 8
Denver 8
Montreal 8
Bremen 7
Da Nang 7
Eugene 7
Genoa 7
Manchester 7
Shinjuku 7
Brno 6
Columbus 6
Guangzhou 6
Haiphong 6
Romola 6
Turin 6
Vienna 6
Amsterdam 5
Aydin 5
Brooklyn 5
Chennai 5
Chieti 5
Fisciano 5
Grimes 5
Hillsboro 5
Kent 5
Kyiv 5
Monselice 5
Naples 5
Padova 5
Quito 5
Ravenna 5
Salt Lake City 5
Salvador 5
Shanghai 5
Taranto 5
Toronto 5
Turku 5
Atlanta 4
Totale 3.354
Nome #
GD2 expression in breast cancer. 427
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 391
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 380
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 375
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 338
Detection of microparticles from human red blood cells by multiparametric flow cytometry 315
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 305
GD2 CAR T cells against human glioblastoma 294
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 256
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 254
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 243
Developing cell therapies as drug products 203
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 198
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 181
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 178
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 153
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 128
Terapia adottiva con linfociti T modificati con un recettore antigenico chimerico (CAR) per la cura di neoplasie GD2-positive 76
Totale 5.122
Categoria #
all - tutte 17.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022405 3 40 15 14 19 40 44 36 41 34 74 45
2022/2023408 47 44 29 39 52 35 12 47 67 8 20 8
2023/2024259 16 15 27 23 34 21 18 32 12 7 12 42
2024/20251.196 26 34 75 98 170 194 138 59 142 49 79 132
2025/20261.922 163 73 160 225 309 109 253 83 165 204 117 61
2026/202747 47 0 0 0 0 0 0 0 0 0 0 0
Totale 5.122